Clinical trials
Urogenital Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
173 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 5 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 10 |
| 2012 | 5 |
| 2013 | 5 |
| 2014 | 10 |
| 2015 | 10 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 7 |
| 2019 | 8 |
| 2020 | 16 |
| 2021 | 15 |
| 2022 | 11 |
| 2023 | 14 |
| 2024 | 16 |
| 2025 | 7 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 60 |
| Recruiting | 42 |
| Active, not recruiting | 21 |
| Terminated | 21 |
| Unknown status | 19 |
| Withdrawn | 6 |
| Not yet recruiting | 2 |
| No longer available | 1 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 10 |
| M.D. Anderson Cancer Center | 7 |
| Steba Biotech S.A. | 6 |
| University Health Network, Toronto | 5 |
| NanOlogy, LLC | 4 |
| British Columbia Cancer Agency | 3 |
| Celldex Therapeutics | 3 |
| Dana-Farber Cancer Institute | 3 |
| Eli Lilly and Company | 3 |
| KU Leuven | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urogenital Neoplasms | 173 |
| Neoplasms | 66 |
| Prostatic Neoplasms | 57 |
| Neoplasms by Site | 44 |
| Breast Neoplasms | 37 |
| Genital Neoplasms, Male | 35 |
| Prostatic Diseases | 29 |
| Urinary Bladder Neoplasms | 28 |
| Gastrointestinal Neoplasms | 26 |
| Urologic Neoplasms | 26 |
Trials
Showing 76 to 100 of 173. Each trial links to its page on Pharma Observatory.
73 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.